Veeco Instruments Inc. reported Q1 2026 revenue of $158.3 million, down from $167.3 million a year earlier, with a GAAP net loss of $0.3 million but a non-GAAP net income of $8.9 million. The company highlighted strong demand driven by AI data centers and silicon photonics, positioning it for multi-year growth. For Q2 2026, Veeco expects revenue between $170 million and $190 million and anticipates continued profitability. The full-year 2026 guidance remains revenue of $740 million to $800 million with GAAP earnings per share between $0.83 and $1.17.
Levi & Korsinsky has started an investigation into Regeneron Pharmaceuticals for potentially misleading investors about the results of a clinical trial. In March 2026, Regeneron's investor relations VP expressed hope for positive trial outcomes of a ...
Levi & Korsinsky has started an investigation into Prestige Consumer Healthcare following the company's failure to meet its Q4 and full-year financial projections, including adjusted gross margin, free cash flow, and adjusted EPS. Additionally, Prest...
Levi & Korsinsky has started an investigation into TriSalus Life Sciences following the company's Q1 2026 revenue of $8.9 million, which missed Wall Street's $9.4 million estimate. The company also lowered its full-year 2026 revenue forecast to $54 m...
Bitcoin whale traders have shifted aggressively toward short positions, reflecting growing defensive sentiment amid weakening broader crypto momentum. Large speculative wallets reduced altcoin exposure and increased leveraged Bitcoin shorts, with one...
Figma has achieved a 46% year-over-year revenue growth and improved its net dollar retention to 139%, showing resilience against fears of AI disruption. The company is transitioning to a usage-based pricing model and benefiting from AI trends, which ...
